FDA Product Code MHX: Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms)
Detecting life-threatening arrhythmias in real time is one of the most critical functions in patient monitoring. FDA product code MHX covers physiological patient monitors with integrated arrhythmia detection.
These systems continuously measure and display vital signs — including ECG, heart rate, blood pressure, and oxygen saturation — while automatically alerting clinicians to dangerous rhythm abnormalities. They are used in intensive care units, cardiac telemetry wards, and operating rooms.
MHX devices are Class II medical devices, regulated under 21 CFR 870.1025 and reviewed by the FDA Cardiovascular panel.
Leading manufacturers include Draeger Medical Systems, Inc., Philips Medizin Systeme Boeblingen GmbH and Ge Medical Systems Information Technologies.
FDA 510(k) Cleared Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms) Devices (Product Code MHX)
About Product Code MHX - Regulatory Context
510(k) Submission Activity
430 total 510(k) submissions under product code MHX since 1987, with 430 receiving FDA clearance (average review time: 139 days).
Submission volume has increased in recent years - 21 submissions in the last 24 months compared to 16 in the prior period - suggesting growing market activity in this device classification.
FDA 510(k) Review Time - MHX Product Code
Recent submissions under MHX have taken an average of 221 days to reach a decision - up from 135 days historically. Manufacturers should account for longer review timelines in current project planning.
MHX devices are reviewed by the Cardiovascular panel. Browse all Cardiovascular devices →